Campbell Newman Asset Management increased its position in Amgen, Inc. (NASDAQ:AMGN) by 0.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 73,579 shares of the medical research company’s stock after buying an additional 644 shares during the period. Amgen makes up […]
